Simponi
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. SIMPONI®(191120)ACMI Golimumab (rmc) Consumer Medicine Information What
Read moreStructural racism thwarts a large proportion of black patients from receiving appropriate lung cancer care, resulting in worse outcomes and
Read moreTwo presentations from the ADAURA clinical trial advanced previous research that demonstrated improved disease-fee survival (DFS) outcomes for patients with
Read moreSORLA is a protein trafficking receptor that has been mainly studied in neurons, but it also plays a role in
Read moreThe NRG Oncology and the American College of Radiology Network (ACRIN) multicenter, phase II trial, NRG-RTOG 1106/ACRIN 6697, is the
Read moreBuilding on the promise of emerging therapies to deploy the body’s natural killer immune cells to fight cancer, researchers at
Read moreWhat makes cancer cells different from ordinary cells? Can these differences be used to strike at them and paralyze their
Read moreResearchers from Queen Mary University of London and Zhengzhou University have developed a powerful therapeutic platform that uses a modified
Read moreSmall cell lung cancer (SCLC) cells are missing a surface protein that triggers an immune response, allowing them to hide
Read more